Mark Meuth
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 1%
Papers in
-
- DNA Repair Mechanisms 25
- Biochemical and Molecular Research 18
- CRISPR and Genetic Engineering 15
- Oncology 18
- Cancer-related Molecular Pathways 10
- Co-authors
- Howard Green (3 shared papers)Thomas Helleday (5 shared papers)Niklas Schultz (3 shared papers)Helen E. Bryant (3 shared papers)Elena López‐Knowles (2 shared papers)Suzanne Kyle (2 shared papers)Nicola J. Curtin (2 shared papers)Huw D. Thomas (2 shared papers)
- Journals
- Molecular and Cellular Biology (11 papers)Nucleic Acids Research (5 papers)Cell (4 papers)Cancer Research (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark Meuth
69 papers receiving 9.0k citations
Mark Meuth's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 3.6k
- Cancer Research 1.4k
- Molecular Biology 6.4k
- Pathology and Forensic Medicine 636
- Genetics 1.0k
Countries citing papers authored by Mark Meuth
This map shows the geographic impact of Mark Meuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Meuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Meuth more than expected).
Fields of papers citing papers by Mark Meuth
This network shows the impact of papers produced by Mark Meuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Meuth. The network helps show where Mark Meuth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Meuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Hit paper breakdown → | 2005 | 3962 |
| 2 | An established pre-adipose cell line and its differentiation in culture Hit paper breakdown → | 1974 | 968 |
| 3 | 2009 | 274 | |
| 4 | 2005 | 261 | |
| 5 | 1989 | 211 | |
| 6 | 2002 | 204 | |
| 7 | 1989 | 200 | |
| 8 | 1974 | 187 | |
| 9 | Apoptosis induced by overexpression of hMSH2 or hMLH1. | 1999 | 162 |
| 10 | 2005 | 155 | |
| 11 | 2007 | 147 | |
| 12 | 2007 | 131 | |
| 13 | 2004 | 131 | |
| 14 | 2010 | 118 | |
| 15 | 2003 | 117 | |
| 16 | 2009 | 111 | |
| 17 | 2008 | 102 | |
| 18 | 1997 | 89 | |
| 19 | 1983 | 89 | |
| 20 | 1984 | 88 |
About Mark Meuth
Mark Meuth is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 72 papers that have together received 9.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (25 papers), Biochemical and Molecular Research (18 papers), CRISPR and Genetic Engineering (15 papers), Cancer-related Molecular Pathways (10 papers), Genetic factors in colorectal cancer (10 papers), Carcinogens and Genotoxicity Assessment (8 papers), HIV/AIDS drug development and treatment (6 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.4k citations), Molecular Biology (6.4k citations), Pathology and Forensic Medicine (636 citations) and Genetics (1.0k citations). Mark Meuth has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Howard Green, Thomas Helleday, Niklas Schultz, Helen E. Bryant, Elena López‐Knowles, Suzanne Kyle, Nicola J. Curtin, Huw D. Thomas, James W.F. Catto and Freddie C. Hamdy. Their work appears in journals such as Molecular and Cellular Biology, Nucleic Acids Research, Cell, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.